Skip to main content
Bioelectricity logoLink to Bioelectricity
. 2019 Sep 16;1(3):139–147. doi: 10.1089/bioe.2019.0012

Cationic Modulation of Voltage-Gated Sodium Channel (Nav1.5): Neonatal Versus Adult Splice Variants—1. Monovalent (H+) Ions

Rustem Onkal 1,,2, Scott P Fraser 1, Mustafa BA Djamgoz 1,,2,
PMCID: PMC8370280  PMID: 34471816

Abstract

Background: Voltage-gated sodium channels are functionally expressed in human carcinomas. In breast and colon cancers, the neonatal splice variant of Nav1.5 (nNav1.5) is dominant. This differs from the adult (aNav1.5) by several amino acids, including an outer charge reversal (residue-211): negatively charged aspartate (aNav1.5) versus positively charged lysine (nNav1.5). Thus, nNav1.5 and aNav1.5 may respond to extracellular charges differently.

Materials and Methods: We used whole-cell patch-clamp recording to compare the electrophysiological effects of the monovalent cation hydrogen (H+) on nNav1.5 and aNav1.5 expressed stably in EBNA cells.

Results: Increasing the H+ concentration (acidifying pH) reduced channel conductance and inhibited peak currents. Also, there was a positive shift in the voltage dependence of activation. These changes were significantly smaller for nNav1.5, compared with aNav1.5.

Conclusions: nNav1.5 was more resistant to the suppressive effects of acidification compared with aNav1.5. Thus, nNav1.5 may have an advantage in promoting metastasis from the acidified tumor microenvironment.

Keywords: Nav1.5, alternative splicing, neonatal, cardiac muscle, breast cancer, pH, H+

Introduction

Voltage-gated sodium channels (VGSCs) open upon membrane depolarization, generating the transient Na+ current (INa) responsible for membrane “excitability” and propagation of action potentials.1,2 Nav1.5 is the major VGSC α-subunit (VGSCα) expressed normally in cardiac muscle, and the activation/inactivation of this channel is vital for normal heart rhythm.3 Consequently, slight changes in Nav1.5 functioning have been associated with a wide range of cardiac conduction disorders, including Brugada syndrome, long-QT syndrome, idiopathic ventricular fibrillation, and arrhythmias.3,4

Alternative splicing occurs in VGSCα genes.5 A major splicing event in SCN5A (the gene encoding Nav1.5) involves exon-6 encoding the region of the voltage sensor/paddle of domain I (DI), including segment 3 (S3), most of segment 4 (S4), and the S3–S4 extracellular linker.6,7 Such DI:S3/S4 splicing was originally described for Nav1.2 and Nav1.3 in rat brain and was shown to be developmentally regulated; transcripts possessing the 5′-exon occur at birth but are rapidly replaced by the 3′-exon.8,9 Accordingly, the 5′ and 3′ variants are referred to as “neonatal” and “adult”, respectively. For Nav1.5, the exon-6 variant proteins differ by seven amino acids, including a “conserved” negatively charged aspartate at position 211 in the adult (aNav1.5) being replaced by a positively charged lysine in the neonatal (nNav1.5).6

In neonatal (1-day old) mouse heart, nNav1.5 protein expression occurs at a level comparable with aNav1.5 but cannot be detected in adult tissue.6 Re-expression of nNav1.5 can occur in mature cardiomyocytes under pathophysiological conditions (e.g., cardiac hypertrophy), where there is a shift to “fetal” ion channels phenotypes.10,11 Interestingly, nNav1.5 is functionally expressed de novo in human metastatic breast and colon cancer cells, where it potentiates Matrigel invasion in vitro as well as metastasis in vivo.12–19 nNav1.5 expression has also been described in human neuroblastoma cells.20

Previously, we demonstrated that aNav1.5 and nNav1.5 expressed stably in EBNA-293 cells differ in their electrophysiological profiles.21 In particular, nNav1.5 channels exhibited significantly more depolarized voltage of activation, hyperpolarized inactivation, slower recovery from inactivation, and slower activation and inactivation kinetics. Changing Lys211 back to Asp211 in nNav1.5 abolished most of the differences, suggesting that the positive electric field induced by Lys211 in the voltage-sensing region of DI was primarily responsible for the observed differences.21 Such change of local electrostatic potential could also affect the interaction with cations and impact channel functioning, especially since the charge reversal is near the voltage sensor. Cations generally are known to inhibit INa in at least two ways: (1) reduction of maximal Na+ conductance and (2) depolarization of voltage dependence of gating.1,22,23 These effects are thought to involve, respectively, pore blockage and neutralization of negative charges on protein surface, for example, external sialic acids and carboxylates.1,22 Thus, nNav1.5 versus aNav1.5 may respond to extracellular charges differently. Effects of various cations on INa were studied in native cardiomyocytes,24,25 and cardiac Purkinje cells.22,26 However, the contributing VGSC(s) were not clear since VGSCαs isoforms additional to Nav1.5 would be present, including Nav1.1–1.4 and Nav1.6.27,28 In contrast, there is less work on cationic modulation of Nav1.5 in isolation.29–31 Furthermore, it is unclear whether the Nav1.5 DI:S3/S4 splice variants would respond differently to cations. It is our hypothesis that the Asp211 to Lys charge reversal would result in the effects of cations on channel gating being smaller for nNav1.5 versus aNav1.5.

In this study, we determined the comparative electrophysiological effects of the monovalent cation hydrogen (H+) on nNav1.5 versus aNav1.5. H+ was selected also because acidosis occurs under hypoxia, including that experienced by ischemic cardiomyocytes and growing tumors.32,33 Indeed, the in vivo tumor microenvironment is well known to be acidic (pH ∼6.5), compared with the normal body pH of ∼7.4. The acidity promotes the invasiveness of cancer cells through a variety of mechanisms, including activation of proteolytic enzymes.33 Results of studies on divalent and trivalent cations are presented in the accompanying article.34

Materials and Methods

Cell culture

Production of EBNA-293 cell lines stably expressing recombinant aNav1.5 and nNav1.5 was described previously.6 Cells were grown as described.21 Cells were maintained in 100 mm Falcon tissue culture dishes (Becton Dickinson) at 37°C, 5% CO2 and 100% relative humidity. For electrophysiology, cells were plated into 35 mm dishes at 10–30% confluence and used within 48 h.

Electrophysiology

Whole-cell patch-clamp recordings were performed as described.21 Patch pipettes were made from borosilicate glass (GC100-F; Harvard Apparatus) using a two-stage puller (PP830; Narashige) and heat polished to 3–5 MΩ when filled with a pipette solution, as described.21 Cs+ was included in the internal patch solution to block endogenous K+ currents.35 Membrane currents were recorded using Axopatch 1D (Axon Instruments) at room temperature, as described.21 Capacitative transients were cancelled and series resistance (Rs) errors were compensated by >85% with a lag of 8 μs. To limit the voltage drop across Rs to <5 mV, data were accepted only as follows: (1) Isolated round cells (≤20 pF) were used. (2) Cells expressed peak INa <6 nA. (3) Activation slope factors were >4.5 mV; steeper slopes would indicate voltage-clamp loss.36,37 (4) Seal resistances were >1 GΩ and initial uncorrected Rs (<10 MΩ) changed <20% during recording. (5) Cells with INa < 500 pA were discarded to avoid bias from any endogenous INa.35

Solutions

Before recording, growth medium was replaced by perfusing cells for ∼15 min with mammalian physiological saline (MPS), as described.21 For changing the H+ level, MPS was titrated with NaOH or HCl to the desired pH (this was confirmed to have remained within 10% of the set value after the recordings). For pH <6.5, HEPES was replaced with MES buffer. The buffer change itself at control pH (7.25) had no effect on INa (data not shown). The solutions were bath-applied at a rate of 1.5 mL/min using a gravity-fed perfusion system. Recordings started 4–5 min after seal rupture to allow time for stabilization.38 In each recording, cells were exposed to “control” and “test” MPS solutions alternatively for at least 2 min each (perfusion switch time <2 s) and voltage pulses were applied in each condition. In all experiments, the order of applying the various doses was randomized. Data were accepted only if the pre- and post-measurements were <10%. Chemicals were from Sigma.

Voltage pulse protocols

Four main types of voltage pulse protocols were used, described previously,21 as follows: (1) Dose–response, (2) current–voltage (I–V), (3) steady-state inactivation, and (4) recovery from inactivation.

Curve fitting and data analysis

Conductance–voltage (G–V) relationships were determined using the equation: G = I/(V − Vrev), where G is conductance, I is current amplitude, V is test voltage, and Vrev is the reversal potential for Na+. For each cell, normalized conductance and steady-state availability were plotted as a function of membrane potential, and fit with a Boltzmann function of the form:

graphic file with name eq1.gif

where Gmax is maximal conductance, Vm is membrane voltage, V1/2 is voltage at which the current is half activated/inactivated, and k is slope factor of voltage sensitivity.

The voltage dependence of time to peak and the time course of inactivation (i.e., decay of current from peak) were fit to the following single and double exponential decay functions, respectively:

graphic file with name eq2.gif
graphic file with name eq3.gif

where A1 and A2 are the coefficients of decline of the time constant (τ) with voltage, V is membrane potential and V0 is a constant describing the voltage dependence of τ. For the double-exponential equation, As and Af are the maximal amplitudes of the slow and fast components of the total current; τfast and τslow are the time constants for decay of the fast and slow components of the current, respectively; the constant C is the asymptote. For the time course of recovery from inactivation, It/Ic was plotted as a function of recovery time (Δt) and fitted to the single exponential function.

Values of Gmax at various H+ concentrations were normalized relative to control values. Dose–response curves for Gmax, activation V1/2, Tpeak, and τfast were fit with the following modified version of the logistic equation since the concentration axis was logarithmic:

graphic file with name eq4.gif

where pKa is the pH at which half-maximum effect occurred.38 All dose–response relationships produced fits where n was not statistically different from unity. It should also be noted that in the extracellular pH (pHo) range tested V1/2 shifts did not saturate, which may have precluded accurate estimation of pKa.

Data analyses

Data were obtained from a minimum of three separate independently plated dishes per condition and combined to give an overall mean ± standard error. Each parameter was determined from a minimum of 10 cells. Statistical analyses were performed using Microsoft Excel and Origin 6.1. Statistical significance was determined with paired or unpaired Student's t-test, as appropriate. Results were considered significant for p < 0.05 (*) and highly significant for p < 0.01 (**).

Results

Effects of H+ on the electrophysiological parameters were studied in the pH range 8.25 to 5.25 changed in steps of 0.5. For all the conditions and parameters studied, the average data obtained for the effects of extracellular H+ (pHo) on nNav1.5 and aNav1.5 are given and compared in Tables 1 and 2.

Table 1.

Effects of H+ on Neonatal and Adult Nav1.5 Electrophysiological Parameters

Parameter Splice variant Control pH 8.25 pHo 6.75 pHo 6.25 pHo 5.75 pHo 5.25 Recovery
Relative Gmax (%) nNav1.5 100.0 ± 0.0 99.3 ± 5.6 87.8 ± 2.5 69.5 ± 3.2 45.3 ± 2.6 21.4 ± 1.3 99.3 ± 4.2
aNav1.5 100.0 ± 0.0 100.2 ± 3.7 85.9 ± 2.8 70.3 ± 1.5 42.7 ± 1.4 20.2 ± 1.5 104.9 ± 2.3
Vthres (mV) nNav1.5 −55.4 ± 0.9 −57.8 ± 0.9 −53.8 ± 1.0 −49.4 ± 1.2 −43.0 ± 1.8 −33.1 ± 2.0 −58.2 ± 1.0
aNav1.5 −60.8 ± 0.8 −62.5 ± 0.9 −59.8 ± 1.1 −55.8 ± 0.8 −47.0 ± 1.2 −35.0 ± 1.2 −62.3 ± 0.7
Vpeak (mV) nNav1.5 −7.3 ± 1.6 −10.0 ± 1.9 −6.5 ± 2.6 −1.9 ± 1.8 5.3 ± 3.0 16.9 ± 2.5 −9.1 ± 2.0
aNav1.5 −22.5 ± 1.9 −25 ± 1.8 −21.0 ± 2.4 −15.8 ± 2.0 −2.7 ± 1.7** 11.0 ± 2.9* −23.6 ± 1.7
Activation V1/2 (mV) nNav1.5 −27.3 ± 1.4 −30.7 ± 1.3 −26.0 ± 2.0 −21.7 ± 1.7 −15.1 ± 2.8 −3.3 ± 2.5 −29.6 ± 1.6
aNav1.5 −39.2 ± 1.2 −42.1 ± 0.8 −39.3 ± 1.6 −32.3 ± 1.3 −22.9 ± 1.5** −7.5 ± 2.0* −41.4 ± 1.1
Activation k nNav1.5 7.5 ± 0.4 7.4 ± 0.5 8.3 ± 0.4 8.5 ± 0.4 9.5 ± 0.4 10.0 ± 0.6 8.0 ± 0.3
aNav1.5 5.2 ± 0.3 5.1 ± 0.4 5.2 ± 0.4 6.2 ± 0.3 7.6 ± 0.3** 10.1 ± 0.6** 5.0 ± 0.2
Inactivation V1/2 (mV) nNav1.5 −89.0 ± 1.6 −84.3 ± 1.3 −74.1 ± 1.4 −92.1 ± 1.5
aNav1.5 −91.0 ± 1.1 −86.1 ± 1.2 −77.1 ± 1.1 −93.0 ± 1.4
Inactivation k nNav1.5 −6.1 ± 0.2 −6.2 ± 0.2 −5.8 ± 0.3 −6.4 ± 0.2
aNav1.5 −5.8 ± 0.2 −6.0 ± 0.2 −6.2 ± 0.7 −6.1 ± 0.2
V0 (mV) nNav1.5 19.8 ± 1.0 19.8 ± 1.6 24.9 ± 2.1 24.3 ± 2.1 23.1 ± 1.8 32.4 ± 9.4 21.2 ± 1.9
aNav1.5 20.7 ± 1.6 24.2 ± 2.4 22.3 ± 1.0 20.9 ± 1.7 18.8 ± 1.1 30.4 ± 8.0 25.2 ± 1.4
Tpeak at 0 mV (ms) nNav1.5 0.77 ± 0.03 0.71 ± 0.01 0.79 ± 0.04 0.92 ± 0.03 1.10 ± 0.07 1.44 ± 0.08 0.69 ± 0.02
aNav1.5 0.58 ± 0.02 0.55 ± 0.01 0.61 ± 0.02 0.70 ± 0.02 0.87 ± 0.03 1.16 ± 0.04 0.57 ± 0.02
τfast at 0 mV (ms) nNav1.5 0.91 ± 0.06 0.84 ± 0.02 0.97 ± 0.08 1.17 ± 0.10 1.42 ± 0.14 2.09 ± 0.25 0.85 ± 0.06
aNav1.5 0.64 ± 0.02 0.61 ± 0.04 0.68 ± 0.03 0.85 ± 0.07 1.06 ± 0.07 1.42 ± 0.06 0.62 ± 0.03
τslow at 0 mV (ms) nNav1.5 5.51 ± 0.24 5.14 ± 0.63 6.41 ± 0.32 7.28 ± 0.45 8.18 ± 0.51 10.31 ± 1.16 5.80 ± 0.30
aNav1.5 5.10 ± 0.24 5.07 ± 0.45 5.60 ± 0.36 6.38 ± 0.44 8.53 ± 0.79 12.68 ± 0.97 5.92 ± 0.56
τrecovery (ms) nNav1.5 22.9 ± 1.2 16.4 ± 1.1 24.1 ± 1.7
aNav1.5 21.7 ± 1.1 16.7 ± 0.8 24.4 ± 1.2

For each parameter (given rows), data are shown for nNav1.5 (above) and aNav1.5 (below) for values of pHo in the range 5.25 to 8.25. Control and recovery values (at the normal pHo 7.25) are matched with pHo 6.25. Data are presented as mean ± standard error of the mean (n ≥ 10). Unpaired t-tests were used to assess whether effects of H+ were differential for nNav1.5 versus aNav1.5.

Significance: *p < 0.05, **p < 0.01.

Gmax, maximal Na+conductance; Vthres, threshold voltage for activation; Vpeak, voltage at which Na+ current is maximal; V1/2, half-maximal voltage; k, slope factor; V0, coefficient describing the voltage dependence of time to peak; Tpeak, time to peak; τfast, fast inactivation decay constant; τslow, slow inactivation decay constant; τrecovery, recovery from inactivation time constant.

Table 2.

Summary of Electrophysiological Effects on H+ on Neonatal and Adult Nav1.5

Parameter Splice variant n pKa Maximum asymptote Minimum asymptote Hill coefficient (nH) R
Relative Gmax (%) nNav1.5 ≥10 5.90 ± 0.14 101.69 ± 2.85 2.73 ± 13.25 0.96 ± 0.20 0.99
aNav1.5 ≥10 5.91 ± 0.14 102.07 ± 3.01 1.01 ± 13.60 0.95 ± 0.20 0.99
Δ activation V1/2 (mV) nNav1.5 ≥10 5.46 ± 0.11 41.01 ± 4.75 −0.95 ± 0.59 −1.04 ± 0.22 0.99
aNav1.5 ≥10 5.43 ± 0.05 54.69 ± 3.08* −1.07 ± 0.36 −1.01 ± 0.14 0.99
Δ Tpeak at 0 mV (ms) nNav1.5 ≥10 5.85 ± 0.10 0.72 ± 0.07 −0.00 ± 0.04 −1.05 ± 0.04 0.97
aNav1.5 ≥10 5.83 ± 0.07 0.58 ± 0.03 −0.00 ± 0.03 −1.02 ± 0.06 0.98
Δ τfast at 0 mV (ms) nNav1.5 ≥10 5.55 ± 0.10 1.38 ± 0.15 −0.01 ± 0.01 −0.99 ± 0.10 1.00
aNav1.5 ≥10 5.48 ± 0.03 1.48 ± 0.16 −0.00 ± 0.02 −0.98 ± 0.09 0.98

For each parameter (given columns), data are shown for nNav1.5 (above) and aNav1.5 (below). pKa values represent pH units. The maximum asymptote (maximum V1/2 shift) for nNav1.5 was restricted at 54.7 mV (i.e., the maximum asymptote for aNav1.5). The maximum asymptote for both fits was restricted at the maximal effect occurring at pHo 5.25. For all parameters studied, the minimum asymptotes were not statistically different from zero. Unpaired Student's t-tests were used to compare the effects on nNav1.5 and aNav1.5.

Significance *p < 0.05.

pKa, pH giving half-maximum effect; R, the correlation coefficient of the mean-least-squares fit.

Gmax and voltage dependence of activation

Acidifying pHo from 7.25 (control) to 5.25 resulted in rapid inhibition of peak INa (Fig. 1A, B). These effects and time courses were similar for both Nav1.5 variants and recovery was complete within <20 s. The effects of H+ on INa and Gmax were determined at various values of pHo (8.25, 6.75, 6.25, 5.75, and 5.25) by changing pHo in random order (Table 1). The alkaline shift (to pHo 8.25) had no effect on peak INa, Gmax or voltage- and time-dependent properties of the Nav1.5 variants (Fig. 1C, D and Table 1). As a control, we should note that the data confirmed the significantly depolarized activation voltage of nNav1.5 versus aNav1.5, reported earlier (Fig. 1D).21

FIG. 1.

FIG. 1.

Effects of H+: Time course of acid block and lack of effect of alkalinization. (A) Typical whole-cell nNav1.5 and aNav1.5 currents in pHo 7.25 (control/wash), pHo 6.25 and pHo 5.25. Currents were elicited by 12 ms depolarizing pulses to −20 mV at 0.1 Hz from a holding potential of −100 mV. Traces shown were recorded at stages (a–e) indicated in (B). Acid block was fully reversible upon washout. Dashed horizontal lines indicate zero current. (B) Time course of onset and offset of acid block of nNav1.5 current (protocol as in A): a, pHo 7.25 (control); b, pHo 6.25; c, pHo 7.25 (washout for pHo 6.25); d, pHo 5.25; e, pHo 7.25 (washout for pHo 5.25). Similar time course for acid block was also obtained for aNav1.5 (not shown). (C) Alkalinization (pHo 8.25) had no effect on peak current amplitude in both Nav1.5 variants. Traces shown are typical whole-cell nNav1.5 currents, before and after exposure to pHo 8.25. Currents were elicited by 60 ms pulses to between −80 and +45 mV from a holding potential of −100 mV; interpulse duration was 2 s. (D) Normalized current–voltage (I–V) relationships for pHo 7.25 (control and washout) and pHo 8.25, showing that alkalinization did not alter voltage dependence of activation of nNav1.5 or aNav1.5. All data are mean ± SEM (n = 5–12). Some error bars are smaller than symbols. SEM, standard error of the mean.

The normalized I–V relationships demonstrated that inhibition of INa by H+ involved two different effects: Gmax was reduced and the activation voltage range was depolarized (Fig. 2A, B). The inhibitory effects of acidifying pHo on Gmax of nNav1.5 and aNav1.5 were statistically similar (Fig. 2A, B and Table 1). Thus, changing pHo from 7.25 to 6.25 caused ∼30% suppression of Gmax in both cases. The Gmax − pHo dose–response relationships also gave similar pKa values (Table 2). For both channel variants, the minimum asymptotes of the fits were not statistically different from zero (Table 2), that is, there was no pHo-independent fraction of INa. A similar result was obtained earlier for aNav1.5.38

FIG. 2.

FIG. 2.

Effects of H+: Acid-induced suppression of peak conductance and depolarization of voltage dependence of activation. (A, B) Normalized peak I–V relationships at each pHo studied (for the range 7.25 to 5.25) for nNav1.5 (A) and aNav1.5 (B). Current amplitudes were normalized to the maximal peak INa recorded at control pHo (7.25). Insets, corresponding conductance transforms. All pre- and post-treatment control data (pHo 7.25) are included to show full recovery from acidic effects and the absence of background time-dependent shifts in voltage dependence of Nav1.5 activation. (C, D) Normalized G–V relationships for each pHo tested, fitted with Boltzmann functions for nNav1.5 (C) and aNav1.5 (D). All data are presented as mean ± SEM (n ≥ 10 cells).

To isolate effects of H+ on voltage dependence of activation, peak conductance was normalized to Gmax for each value of pHo, and data were fit to the Boltzmann function (Eq. 1) on a cell-by-cell basis (Fig. 2C, D). For decreasing pHo, progressive depolarization of activation-V1/2 and slope factor k increases were observed. For both channel variants, these effects were statistically significant for changes in pHo from 7.25 to ≤6.25 (p < 0.05 vs. control; Fig. 2C, D and Table 1). Importantly, these changes were significantly smaller for nNav1.5 versus aNav1.5 at pHo ≤ 5.75 (Table 1). Consistent with these differential effects, logistic fits to the activation-V1/2 data yielded a significant (∼14 mV) larger maximum asymptote for aNav1.5 versus nNav1.5 (Table 2). In contrast, pKa values were similar (Table 2).

Threshold of activation (Vthres) and voltage for peak INa (Vpeak) were also depolarized in acidified solutions (Fig. 2A, B and Table 1). Shifts in Vthres were statistically significant for change of pHo to ≤6.25 (p < 0.05 vs. control); however, there was no difference between the two Nav1.5 variants (Table 1). Shifts in Vpeak, which were also statistically significant for pHo ≤ 6.25 (p < 0.05 vs. control), were larger for aNav1.5 versus nNav1.5 at pHo 5.75 and 5.25 (Table 1). Finally, block of INa by acidification (studied at pHo 6.25) was voltage dependent for both Nav1.5 variants, the effect being significantly greater at negative potentials, peaking at −45 mV for both. It is possible that the accompanying positive shifts in activation gating (in particular Vthres) contributed to this effect. Nevertheless, in the voltage range −45 to −55 mV, this effect of voltage was smaller by 17–57% for nNav1.5 versus aNav1.5 (p < 0.05 for all).

Kinetics of activation and inactivation

Activation and inactivation kinetics were slowed in acid pHo (Table 1). For both Nav1.5 variants, the slowing of time to peak (Tpeak) was significant for pHo ≤ 6.25 but similar for both Nav1.5 variants (Table 1). Logistic fits to the acid-induced shifts at 0 mV produced comparable pKa values (Table 2). The voltage dependence of Tpeak was not altered (p > 0.05 vs. control; Table 1). Double exponential fits (Eq. 3) to INa decays suggested that currents decayed more slowly at pHo ≤ 6.25. Thus, fast (τfast) and slow (τslow) time constants of inactivation were increased, but this was similar for both variants (Table 1).

Availability and recovery from inactivation

Acidifying pHo depolarized the inactivation-V1/2 significantly but similarly for both Nav1.5 variants (p < 0.05 vs. control for both), whereas the slope factor was not affected (Fig. 3A, C, E and Table 1). Overall, acid-induced shifts in inactivation-V1/2 were smaller than for activation-V1/2 (Table 1). Acidosis significantly quickened recovery from inactivation (τrecovery) (p < 0.05 vs. control); this was similar for both splice variants (Fig. 3B, D, F and Table 1).

FIG. 3.

FIG. 3.

Effects of H+: Acid-induced depolarization of steady-state inactivation and acceleration of recovery from inactivation. (A) Typical whole-cell nNav1.5 currents in pHo 7.25 (control) and pHo 6.25. (B) Superimposed whole-cell Na+ currents from nNav1.5 recovery from inactivation, in pHo 7.25 (i) and pHo 6.25 (ii). Arrows indicate acid-induced acceleration of current recovery. (C, E) Availability-voltage relationships in pHo 7.25 (control/wash), pHo 6.25, and pHo 5.25 fitted with Boltzmann functions for nNav1.5 (C) and aNav1.5 (E). (D, F) Recovered current (It/Ic) in pHo 7.25 (control/wash) and pHo 6.25, plotted as a function of stimulation interval and fitted with single exponential functions for nNav1.5 (D) and aNav1.5 (F). Significance (paired t-tests vs. control): *p < 0.05, **p < 0.01. Data are mean ± SEM. (n = 10–19).

Discussion

In this study, the electrophysiological effects of H+ were compared for “adult” versus “neonatal” splice variants of Nav1.5. The main findings were as follows: (1) H+ inhibited peak INa through reducing Gmax and inducing a positive shift in voltage dependence of activation. (2) Proton block of Gmax was similar for the two Nav1.5 variants, but the acid-induced depolarization of voltage dependence of activation was significantly smaller for nNav1.5 compared with aNav1.5. These results are discussed in relation to possible mode(s) of action of H+ and the difference in the charged amino acids of nNav1.5 versus aNav1.5.

Acid block of INa has been studied in native cardiomyocytes, neurons, skeletal muscle as well as recombinantly expressed VGSCs.24,25,29–31,38–43 Consistent with the results presented in this study, two distinct effects of extracellular acidosis on VGSCs have been routinely observed: reduction of Gmax and depolarization of voltage dependence of channel gating. In addition, effects on slow and use-dependent inactivation, not determined in this study, have been reported for Nav1.2/1.4/1.5.29–31,41,42

The precise mechanism(s) of acid block of Na+ conductance is not understood. For Nav1.5, this is thought to involve four outer-ring amino acids (i.e., the “EEDD” motif) and the “TTX-sensitivity determining” Cys373 located just above the selectivity-filter in DI.30,38,44 In addition, His880, located at the top of the P1 helix of DII, has been found to contribute to modulation of slow inactivation kinetics and use-dependent inactivation by acidosis.30 In contrast, selectivity-filter carboxyl groups (“DEKA” motif) were found to be protected from protonation possibly because of their proximity to the positive lysine residue (K) present.38,44

In previous studies, no pHo-independent fraction of Na+ conductance was found for Nav1.5 (unlike for Nav1.4).30,38 This was also found in this study and could be due, in part, to the protonation of Cys373 in DI.30,38 Also, proton inhibition of peak Na+ conductance has been shown to be well represented by a single-site binding model.38,40 This was also found with block of Gmax being fit best by a Hill equation for a single site. This gave pKa values of ∼5.9 for both nNav1.5 and aNav1.5, which compare well with previously reported values for aNav1.5.29,30,38 Similar values of pKa were found for Nav1.4 and shown to be independent of β1 subunit co-expression.40,44,45

The similarity in the values of pKa for Gmax of nNav.5 and aNav1.5 is consistent with the spliced DI:S3/S4 region being located peripheral to the outer vestibule of the channel pore, as suggested by X-ray crystal structures of the bacterial sodium channel and the mammalian voltage-gated K+ channel.46,47 Furthermore, mutagenesis of the outer ring negative carboxylates in various VGSCα isoforms to neutral or positive residues had no detectable effect on voltage dependence of activation, again suggesting that channel voltage sensors are distant from the outer vestibule residues.44,45,48,49 Taken together, therefore, the spliced DI:S3/S4 region (including the charge-reversing Lys-211-Asp) must be sufficiently away from the channel outer vestibule that the amino acid changes between nNav1.5 and aNav1.5 do not appear structurally or electrostatically to modify the acidic inhibition of Na+ permeation.

As regards channel gating, acid pHo depolarized steady-state activation and inactivation, slowed activation and inactivation kinetics, and accelerated recovery from inactivation in both Nav1.5 variants. These results agree with previous studies.24,38,45,50 On the whole, the observed effects of protons on VGSC gating may be due to screening or titrating the negatively charged sialic acids and carboxylates on the channel surface, resulting in (1) reduction of negative surface potential and (2) positive shift in activation voltage.1 However, other mechanism(s), such as direct channel block, may also be involved.1,24,40,44

Importantly, the pHo dependence of activation differed significantly between the two variants. Thus, acidifying pHo to ≤5.75 shifted activation V1/2, k, and Vpeak of aNav1.5 significantly more than nNav.15 (Table 1). These results are consistent with our hypothesis that substitution of the negatively charged Asp211 to the positive Lys211 in the DI:S3–S4 region (close to the voltage sensor) should reduce the apparent effect of protonation on voltage dependence of activation of nNav1.5. In agreement with this, earlier studies also have reported that acidic residues in S3–S4 linkers are important determinants of cationic effects on channel gating.51,52

Conclusion

We hypothesized that H+ effects on channel gating would be smaller for nNav1.5 versus aNav1.5, since the negative surface potential near D1:S4 may already be partly reduced due to the Asp211 to Lys charge reversal in nNav1.5. Taken together, the data clearly indicate that nNav1.5 is more acid resistant than aNav1.5. This has important implications regarding the involvement of nNav1.5 in cancer. First, many tumors grow under hypoxia, resulting in acidic conditions.53 Second, in the breast cancer cell line MDA-MB-231, nNav1.5 activity leads to an intracellular alkalinization and pericellular acidification favoring increased protease activity, enhancing invasiveness.54 Thus, expression of nNav1.5 (vs. aNav1.5) would mean better maintained VGSC activity within the acidic environment, enhancing its contribution to metastatic cell behaviors.12 Finally, low pHo also increases the late (“persistent”) Na+ current critical to metastatic cell behaviors.55 Ranolazine, a specific inhibitor of the persistent Na+ currents, is currently clinically approved for treatment of angina pectoris.41 Importantly, ranolazine has been shown to work in a pH-dependent manner on Nav1.5, with increasing effectiveness at acidic pH.41 Thus, such a drug may have potential as an anti-metastatic agent.55

Authors' Contributions to and Responsibilities for the Article

M.B.A.D. and R.O. conceived the research. S.P.F. and R.O. performed the experiments and did the analyses. All authors contributed to writing the article. All coauthors have reviewed and approved of the article before submission.

This article has been submitted solely to Bioelectricity and is not published, in press, or submitted elsewhere.

Author Disclosure Statement

M.B.A.D. is involved in a spinout company (Celex Oncology Ltd) focused on ion channels and cancer. S.P.F. and R.O. declare no competing financial interests.

Funding Information

We thank Pro Cancer Research Fund (PCRF) for continuous support (M.B.A.D.; S.P.F.). R.O. was funded by a PhD studentship from the British Heart Foundation (BHF).

References

  • 1.Hille B.Ionic Channels of Excitable Membranes, 3rd edition. Sunderland, MA: Sinauer Associates, Inc., 2001 [Google Scholar]
  • 2.Catterall WA, Raman IM, Robinson HPC, et al. The Hodgkin-Huxley heritage: From channels to circuits. J Neurosci 2012;32:14064–14073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Abriel H. Cardiac sodium channel Nav1.5 and interacting proteins: Physiology and pathophysiology. J Mol Cell Cardiol 2010;48:2–11 [DOI] [PubMed] [Google Scholar]
  • 4.Zaklyazminskaya E, Dzemeshkevich S. The role of mutations in the SCN5A gene in cardiomyopathies. Biochim Biophys Acta 2016;1863:1799–805 [DOI] [PubMed] [Google Scholar]
  • 5.Diss JKJ, Fraser SP, Djamgoz MBA. Voltage-gated Na+ channels: Multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur Biophys J 2004;33:180–193 [DOI] [PubMed] [Google Scholar]
  • 6.Chioni AM, Fraser SP, Pani F, et al. A novel polyclonal antibody specific for the Nav1.5 voltage-gated Na+ channel ‘neonatal’ isoform. J Neurosci Methods 2005;147:88–98 [DOI] [PubMed] [Google Scholar]
  • 7.Swartz KJ. Sensing voltage across lipid membranes. Nature 2008;456:891–897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sarao R, Gupta SK, Auld VJ, et al. Developmentally regulated alternative RNA splicing of rat-brain sodium-channel messenger-RNAs. Nucleic Acids Res 1991;19:5673–5679 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gustafson TA, Clevinger EC, Oneill TJ, et al. Mutually exclusive exon splicing of type-III brain sodium channel-alpha subunit RNA generates developmentally-regulated isoforms in rat-brain. J Biol Chem 1993;268:18648–18653 [PubMed] [Google Scholar]
  • 10.Huang B, El-Sherif T, Gidh-Jain M, et al. Alterations of sodium channel kinetics and gene expression in the postinfarction remodeled myocardium. J Cardiovasc Electrophysiol 2001;12:218–225 [DOI] [PubMed] [Google Scholar]
  • 11.Kuwahara K, Saito Y, Takano M, et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003;22:6310–6321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Fraser SP, Diss JKJ, Chioni A-M, et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 2005;11:5381–5389 [DOI] [PubMed] [Google Scholar]
  • 13.Brisson L, Gillet L, Calaghan S, et al. Nav1.5 enhances breast cancer cell invasiveness by increasing NHE1-dependent H+ efflux in caveolae. Oncogene 2011;30:2070–2076 [DOI] [PubMed] [Google Scholar]
  • 14.House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 2010;70:6957–6967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Baptista-Hon DT, Robertson FM, Robertson GB, et al. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and Nav1.5 channel function. Br J Anaesth 2014;113:i39–i48 [DOI] [PubMed] [Google Scholar]
  • 16.Driffort V, Gillet L, Bon E, et al. Ranolazine inhibits Nav1.5-mediated breast cancer cell invasiveness and lung colonization. Mol Cancer 2014;13:264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nelson M, Yang M, Millican-Slater R, et al. Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo. Oncotarget 2015;6:32914–32929 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Guzel RM, Ogmen K, Ilieva KM, et al. Colorectal cancer invasiveness in vitro: Predominant contribution of neonatal Nav1.5 under normoxia and hypoxia. J Cell Physiol 2019;234:6582–6593 [DOI] [PubMed] [Google Scholar]
  • 19.Brackenbury WJ, Chioni AM, Diss JK, Djamgoz MBA. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 2007;101:149–160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ou SW, Kameyama A, Hao LY, et al. Tetrodotoxin-resistant Na+ channels in human neuroblastoma cells are encoded by new variants of Nav1.5/SCN5A. Eur J Neurosci 2005;22:793–801 [DOI] [PubMed] [Google Scholar]
  • 21.Onkal R, Mattis JH, Fraser SP, et al. Alternative splicing of Nav1.5: An electrophysiological comparison of ‘neonatal’ and ‘adult’ isoforms and critical involvement of a lysine residue. J Cell Physiol 2008;216:716–726 [DOI] [PubMed] [Google Scholar]
  • 22.Hanck DA, Sheets MF. Extracellular divalent and trivalent cation effects on sodium current kinetics in single canine cardiac Purkinje cells. J Physiol 1992;454:267–298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Peters CH, Ghovanloo MR, Gershome C, et al. pH modulation of voltage-gated sodium channels. Handb Exp Pharmacol 2018;246:147–160 [DOI] [PubMed] [Google Scholar]
  • 24.Zhang JF, Siegelbaum SA. Effects of external protons on single cardiac sodium channels from guinea pig ventricular myocytes. J Gen Physiol 1991;98:1065–1083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Watson CL, Gold MR. Effect of intracellular and extracellular acidosis on sodium current in ventricular myocytes. Am J Physiol 1995;268:1749–1756 [DOI] [PubMed] [Google Scholar]
  • 26.Sheets MF, Hanck DA. Mechanisms of extracellular divalent and trivalent cation block of the sodium current in canine cardiac Purkinje cells. J Physiol 1992;454:299–320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Haufe V, Camacho JA, Dumaine R, et al. Expression pattern of neuronal and skeletal muscle voltage-gated Na+ channels in the developing mouse heart. J Physiol 2005;564:683–696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kaufmann SG, Westenbroek RE, Zechner C, et al. Functional protein expression of multiple sodium channel alpha- and beta-subunit isoforms in neonatal cardiomyocytes. J Mol Cell Cardiol 2010;48:261–269 [DOI] [PubMed] [Google Scholar]
  • 29.Jones DK, Peters CH, Tolhurst SA, et al. Extracellular proton modulation of the cardiac voltage-gated sodium channel, Nav1.5. Biophys J 2011;101:2147–2156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jones DK, Peters CH, Allard CR, et al. Proton sensors in the pore domain of the cardiac voltage-gated sodium channel. J Biol Chem 2013;288:4782–4791 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Vilin YY, Peters CH, Ruben PC. Acidosis differentially modulates inactivation in Nav1.2, Nav1.4, and Nav1.5 channels. Front Pharmacol 2012;3:109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Karmazyn M, Gan XT, Humphreys RA, et al. The myocardial Na+-H+ exchange: Structure, regulation, and its role in heart disease. Circ Res 1999;85:777–786 [DOI] [PubMed] [Google Scholar]
  • 33.Brahimi-Horn MC, Pouysségur J. Harnessing the hypoxia-inducible factor in cancer and ischemic disease. Biochem Pharmacol 2007;73:450–457 [DOI] [PubMed] [Google Scholar]
  • 34.Onkal R, Fraser SP, Djamgoz MBA. Cationic modulation of voltage-gated sodium channel (Nav1.5): Neonatal versus adult splice Variants–2. Divalent (Cd2+) and Trivalent (Gd3+) Ions. Bioelectricity 2019. [Epub ahead of print]; DOI: 10.1089/bioe.2019.0014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kurejová M, Uhrík B, Sulová Z, et al. Changes in ultrastructure and endogenous ionic channels activity during culture of HEK 293 cell line. Eur J Pharmacol 2007;567:10–18 [DOI] [PubMed] [Google Scholar]
  • 36.Stocker PJ, Bennett ES. Differential sialylation modulates voltage-gated Na+ channel gating throughout the developing myocardium. J Gen Physiol 2006;127:253–265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cummins TR, Rush AM, Estacion M, et al. Voltage-clamp and current-clamp recordings from mammalian DRG neurons. Nat Protoc 2009;4:1103–1112 [DOI] [PubMed] [Google Scholar]
  • 38.Khan A, Kyle JW, Hanck DA, et al. Isoform-dependent interaction of voltage-gated sodium channels with protons. J Physiol 2006;576:493–501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Tombaugh GC, Somjen GG. Effects of extracellular pH on voltage-gated Na+, K+ and Ca2+ currents in isolated rat CA1 neurons. J Physiol 1996;493:719–732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bénitah J, Balser JR, Marban E, et al. Proton inhibition of sodium channels: Mechanism of gating shifts and reduced conductance. J Membr Biol 1997;155:121–131 [DOI] [PubMed] [Google Scholar]
  • 41.Sokolov S, Peters CH, Rajamani S, et al. Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine. Front Pharmacol 2013;4:78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nakamura M, Jang I-S. Acid modulation of tetrodotoxin-resistant Na+ channels in rat nociceptive neurons. Neuropharmacology 2015;90:82–89 [DOI] [PubMed] [Google Scholar]
  • 43.Ghovanloo M-R, Peters CH, Ruben PC. Effects of acidosis on neuronal voltage-gated sodium channels: Nav1.1 and Nav1.3. Channels 2018;12:367–377 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Khan A, Romantseva L, Lam A, et al. Role of outer ring carboxylates of the rat skeletal muscle sodium channel pore in proton block. J Physiol 2002;543:71–84 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sun YM, Favre I, Schild L, et al. On the structural basis for size-selective permeation of organic cations through the voltage-gated sodium channel. Effect of alanine mutations at the DEKA locus on selectivity, inhibition by Ca2+ and H+, and molecular sieving. J Gen Physiol 1997;110:693–715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Swartz KJ. Sensing voltage across lipid membranes. Nature 2008;456:891–897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Catterall WA, Swanson TM. Structural basis for pharmacology of voltage-gated sodium and calcium channels. Mol Pharmacol 2015;88:141–150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Terlau H, Heinemann SH, Stühmer W, et al. Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett 1991;293:93–96 [DOI] [PubMed] [Google Scholar]
  • 49.Chiamvimonvat N, Pérez-García MT, Tomaselli GF, et al. Control of ion flux and selectivity by negatively charged residues in the outer mouth of rat sodium channels. J Physiol 1996;491:51–59 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Yatani A, Brown AM, Akaike N. Effect of extracellular pH on sodium current in isolated, single rat ventricular cells. J Membr Biol 1984;78:163–168 [DOI] [PubMed] [Google Scholar]
  • 51.Henrikson CA, Xue T, Dong P, et al. Identification of a surface charged residue in the S3–S4 linker of the pacemaker (HCN) channel that influences activation gating. J Biol Chem 2003;278:13647–13654 [DOI] [PubMed] [Google Scholar]
  • 52.Sørensen JB, Cha A, Latorre R, et al. Deletion of the S3–S4 linker in the Shaker potassium channel reveals two quenching groups near the outside of S4. J Gen Physiol 2000;115:209–222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Abaza M, Luqmani YA. The influence of pH and hypoxia on tumor metastasis. Expert Rev Anticancer Ther 2013;13:1229–1242 [DOI] [PubMed] [Google Scholar]
  • 54.Gillet L, Roger S, Besson P, et al. Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J Biol Chem 2009;284:8680–8691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Djamgoz MBA, Onkal R. Persistent current blockers of voltage-gated sodium channels: A clinical opportunity for controlling metastatic disease. Recent Pat Anticancer Drug Discov 2013;8:66–84 [DOI] [PubMed] [Google Scholar]

Articles from Bioelectricity are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES